Khrysos Industries, Inc. Secures Rights to Produce Hand Sanitizer from FDA
April 7, 2020
Khrysos Industries, Inc., a wholly-owned subsidiary of Youngevity International, Inc. (NASDAQ: YGYI), announced Tuesday that the company has begun producing hand sanitizer in various sizes, including 2 oz, 4 oz, 8 oz, and 1-gallon packaging. The company was granted a license by the Food and Drug Administration (FDA) to begin producing hand sanitizer in its Orlando, FL facility.
Khrysos Industries disclosed that there is a demand for hand sanitizer for retail distribution and within the health care system, including retirement homes and hospitals.
“We believe our operation provides us the opportunity to help meet the demand for hand sanitizer for the health care industry as well as retail consumers to help protect against the spread of COVID-19,” said Dwayne Dundore Ph.D., President of Khrysos. He continued, “It takes tremendous effort to source all the components, especially the packaging material, to produce this product, but our team is up for the challenge given the magnitude of the need.”
The company brought online a state-of-the-art facility that features a 46,200 sq. ft. production area that includes 5,200 sq. ft. of class C7 sterile capable workspace late last year and expect to be well-positioned to utilize its operation to produce hand sanitizer that is in high demand due to the impact of the coronavirus.
“We began shipping hand sanitizer today and expect to ramp up production as necessary to meet the demand that is still in short supply,” said Dave Briskie, President and CFO of YGYI, about its wholly-owned subsidiary Khrysos Industries. He continued, “Our team at Khrysos is taking great pride in providing this product especially to the nurses and doctors that are out there on the front line fighting for those inflicted with this horrible virus.”